ARTICLE | Clinical News
Olmesartan regulatory update
February 22, 2010 8:00 AM UTC
FDA approved an sNDA for Benicar olmesartan to treat hypertension in children and adolescents ages 6-16. The angiotensin receptor blocker is already marketed to treat hypertension in adults. ...